title: Longterm followup of quality of life in patients with cryopyrin-associated periodic syndrome treated with canakinumab, an anti-interleukin 1β monoclonal antibody.
authors.affiliation: Department of Pediatric Rheumatology and Division of Pediatrics, CEREMAI, University of Paris SUD, Bicêtre Hospital, Assistance Publique Hôpitaux de Paris, Le Kremlin Bicêtre, Paris, France. celine.marsaud@bct.aphp.fr.
authors.forename: Céline
authors.initials: C
authors.lastname: Marsaud
authors.affiliation: Department of Pediatric Rheumatology and Division of Pediatrics, CEREMAI, University of Paris SUD, Bicêtre Hospital, Assistance Publique Hôpitaux de Paris, Le Kremlin Bicêtre, Paris, France.
authors.forename: Isabelle
authors.initials: I
authors.lastname: Marie
authors.affiliation: Department of Pediatric Rheumatology and Division of Pediatrics, CEREMAI, University of Paris SUD, Bicêtre Hospital, Assistance Publique Hôpitaux de Paris, Le Kremlin Bicêtre, Paris, France.
authors.forename: Isabelle
authors.initials: I
authors.lastname: Koné-Paut
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D056587:Cryopyrin-Associated Periodic Syndromes / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D005500:Follow-Up Studies; D006801:Humans; D053583:Interleukin-1beta / Q000276:immunology*; D008137:Longitudinal Studies; D008875:Middle Aged; D011788:Quality of Life; D012189:Retrospective Studies; D012720:Severity of Illness Index; D011795:Surveys and Questionnaires; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D053583:Interleukin-1beta; C541220:canakinumab